Literature DB >> 1902856

Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma.

W Y Almawi1, M L Lipman, A C Stevens, B Zanker, E T Hadro, T B Strom.   

Abstract

Glucocorticoids (GCS) inhibit the transcription of multiple activation-associated cytokine genes. By Northern blot analysis now we demonstrate that antiproliferative concentrations of dexamethasone and 6 alpha-methylprednisolone block mitogen-induced IL-2 gene expression in human peripheral blood mononuclear leukocytes in a concentration-dependent fashion. In addition, using a mitogen-induced proliferation assay of human peripheral blood mononuclear leukocytes, we show that GCS-mediated anti-proliferative effects are not blocked by rIL-1, rIL-2, rIL-3, rIL-4, rIL-5, rIL-6, rTNF-alpha, rTNF-beta, and rIFN-gamma, individually at 1 to 1000 U/ml, but are totally abrogated, in a concentration-dependent fashion, by the combination of rIL-1, rIL-6, and rIFN-gamma (25 to 50 U/ml for each cytokine). Thus, blockade of cytokine expression is the primary mechanism by which GCS inhibit mitogen-driven and alloantigen-induced T cell proliferation. The immunosuppressive effects of GCS are almost certainly exacted at the level of cytokine gene transcription.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Four decades of glucocorticosteroid immunosuppression.

Authors:  P F Halloran
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

2.  Endogenous cortisol regulates immunoglobulin E-dependent late phase reactions.

Authors:  R F Herrscher; C Kasper; T J Sullivan
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques.

Authors:  C Meyer; J Walker; J Dewane; F Engelmann; W Laub; S Pillai; Charles R Thomas; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2015-06-29       Impact factor: 4.330

Review 4.  Immunobiology and immunopharmacology of organ allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

5.  Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.

Authors:  C Stevens; G Walz; C Singaram; M L Lipman; B Zanker; A Muggia; D Antonioli; M A Peppercorn; T B Strom
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

6.  Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis.

Authors:  R Harley; C R Helps; D A Harbour; T J Gruffydd-Jones; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 7.  Management of hyperglycaemia after pancreas transplantation: are new immunosuppressants the answer?

Authors:  Francesca M Egidi
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 8.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

9.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

10.  Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals.

Authors:  A M Jevnikar; G G Singer; D C Brennan; H W Xu; V R Kelley
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.